Sivanna Umesh, Joshi Shreedhar, Babu Balaji, Jagadeesh A M
Department of Cardiac Anaesthesiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India.
Indian J Anaesth. 2015 May;59(5):282-6. doi: 10.4103/0019-5049.156867.
Perioperative myocardial ischaemia (PMI) is one of the known complications during off pump coronary artery bypass (OPCAB) surgeries. The length of hospital stay is considerably prolonged in patients with PMI. Myocardial protection is an area which is being widely researched currently to prevent or reduce the incidence of PMI. Over the last decade it has become clear that volatile anaesthetic agents are protective in the setting of PMI and reperfusion. Hence, we planned to study the effect of two different volatile anaesthetics as myocardial protective agents in OPCAB surgery.
A total of 40 patients were enrolled for the study; Group A (sevoflurane, n = 20) and Group B (desflurane, n = 20). All patients had a baseline measurement of Trop-T, creatine phosphokinase-MB (CPKMB) and myocardial performance index (MPI) pre-operatively, which was repeated 4 h after the surgery. Chi-square/Fisher test was used to find the significance of the differences between the two agents.
Patients were comparable in demographic, baseline, biochemical and echo criteria. Post-operative CPKMB levels (desflurane - 30.85 ± 2.69 u/L; sevoflurane - 29.05 ± 5.26 u/L, P = 0.7) and number of Trop-T positive patients (Sevoflurane - 9; desflurane - 6, P ≥ 0.05) were comparable. Post-operative MPI indicated decreased left ventricular function in sevoflurane group as compared to desflurane group (P ≤ 0.03).
Desflurane exerts better cardioprotective effect than sevoflurane as indicated by better MPI in OPCAB surgeries.
围手术期心肌缺血(PMI)是非体外循环冠状动脉搭桥术(OPCAB)手术中已知的并发症之一。PMI患者的住院时间会显著延长。心肌保护是目前正在广泛研究的一个领域,以预防或降低PMI的发生率。在过去十年中,已经明确挥发性麻醉剂在PMI和再灌注情况下具有保护作用。因此,我们计划研究两种不同的挥发性麻醉剂作为OPCAB手术中心肌保护剂的效果。
共有40例患者纳入本研究;A组(七氟醚,n = 20)和B组(地氟醚,n = 20)。所有患者术前均对肌钙蛋白T(Trop-T)、肌酸磷酸激酶同工酶MB(CPKMB)和心肌性能指数(MPI)进行基线测量,并在术后4小时重复测量。采用卡方检验/费舍尔检验来确定两种药物之间差异的显著性。
患者在人口统计学、基线、生化和超声标准方面具有可比性。术后CPKMB水平(地氟醚 - 30.85 ± 2.69 U/L;七氟醚 - 29.05 ± 5.26 U/L,P = 0.7)和Trop-T阳性患者数量(七氟醚 - 9例;地氟醚 - 6例,P≥0.05)具有可比性。术后MPI显示七氟醚组左心室功能较地氟醚组下降(P≤0.03)。
在OPCAB手术中,地氟醚比七氟醚具有更好的心脏保护作用,这一点通过更好的MPI得以体现。